“Oral Bioavailability Enhancement of Doxazosin Mesylate: Nanosuspension Versus Self-Nanoemulsifying Drug Delivery Systems”. ADMET and DMPK 12, no. 1 (November 3, 2023): 167–176. Accessed September 1, 2026. https://pub.iapchem.org/ojs/index.php/admet/article/view/2022.